Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Other financing activities (2021 - 2025)

Senti Biosciences (SNTI) has 3 years of Other financing activities data on record, last reported at $12000.0 in Q3 2025.

  • For Q3 2025, Other financing activities changed N/A year-over-year to $12000.0; the TTM value through Sep 2025 reached $2.7 million, up 415.45%, while the annual FY2024 figure was $100000.0, N/A changed from the prior year.
  • Other financing activities reached $12000.0 in Q3 2025 per SNTI's latest filing, down from $533000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.9 million in Q1 2025 and bottomed at $12000.0 in Q3 2025.
  • Average Other financing activities over 3 years is $609755.7, with a median of $523430.0 recorded in 2021.